4//SEC Filing
Gold Lawrence Marshall 4
Accession 0001213900-22-002421
CIK 0001690080other
Filed
Jan 17, 7:00 PM ET
Accepted
Jan 18, 4:32 PM ET
Size
5.0 KB
Accession
0001213900-22-002421
Insider Transaction Report
Form 4
Gold Lawrence Marshall
Director
Transactions
- Award
Common Stock
2022-01-14$3.04/sh+4,728$14,373→ 11,458 total
Footnotes (1)
- [F1]Issued in consideration for serving on the Board of Directors, as a Member of the Audit Committee and as Chairman of the Nominating and Corporate Governance Committee of the Board of Directors, for the quarter ended December 31, 2021. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt from Section 16(b) pursuant to Rule 16b-3.
Documents
Issuer
180 Life Sciences Corp.
CIK 0001690080
Entity typeother
Related Parties
1- filerCIK 0001355868
Filing Metadata
- Form type
- 4
- Filed
- Jan 17, 7:00 PM ET
- Accepted
- Jan 18, 4:32 PM ET
- Size
- 5.0 KB